CAJ | 학술논문

肺癌是临床上最常见的恶性肿瘤之一，且大多数肺癌发现时即为晚期。传统治疗手段受制于各种瓶颈的制约，远期有效率较低，故早期手术患者死于复发和远处转移。随着技术的发展，肺癌的免疫治疗取得了突破性的发展，免疫治疗已经成为肺癌治疗的新方法，该文就目前文献报道的关于免疫治疗的药物及临床研究进行综述。
폐암시림상상최상견적악성종류지일，차대다수폐암발현시즉위만기。전통치료수단수제우각충병경적제약，원기유효솔교저，고조기수술환자사우복발화원처전이。수착기술적발전，폐암적면역치료취득료돌파성적발전，면역치료이경성위폐암치료적신방법，해문취목전문헌보도적관우면역치료적약물급림상연구진행종술。
Lung cancer is clinically one of the most common malignant tumors, and most of the lung cancer is advanced when found. Restricted by many bottlenecks, conventional treatment always bring lower long-term effective rate and patients who underwent surgery at early stage often died of recurrence and distant metastasis. With the development of technology, breakthrough has been made in immunotherapy which becomes a new method for the treatment of lung cancer. In this arti-cle, we review the literature and clinical research on the treatment of immunotherapy.